Macrolides, one of the most prescribed classes of antibiotics, bind in the bacterial ribosome's polypeptide exit tunnel and inhibit translation. However, mutations and other ribosomal modifications, especially to the base A2058 of the 23S rRNA, have led to a growing resistance problem. Here, we have used molecular dynamics simulations to study the macrolides erythromycin and azithromycin in wild-type, A2058G-mutated, and singly or doubly A2058-methylated Escherichia coli ribosomes. We find that the ribosomal modifications result in less favorable interactions between the base 2058 and the desosamine sugar of the macrolides, as well as greater displacement of the macrolides from their crystal structure position, illuminating the causes of resistance. We have also examined four azithromycin derivatives containing aromatic indole-analog moieties, which were previously designed based on simulations of the stalling peptide SecM in the ribosome. Surprisingly, we found that the studied moieties could adopt very different geometries when interacting with a key base in the tunnel, A751, possibly explaining their distinct activities. Based on our simulations, we propose modifications to the indole-analog moieties that should increase their interactions with A751 and, consequently, enhance the potency of future azithromycin derivatives.
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| INTRODUCTION
Macrolides bind to the bacterial ribosome and inhibit protein synthesis. They are one of the most prescribed classes of antibiotics and are frequently used for infections with penicillinresistant bacteria or in penicillin-allergic patients. [1, 2] Macrolides comprise a large, 14-to 16-atom macrolactone ring with attached sugar moieties. Since the discovery of the first macrolide, erythromycin, which is naturally produced by Saccharopolyspora erythraea, several second-generation macrolides with improved stability and efficacy, such as azithromycin, have been developed [3, 4] (see Scheme 1a).
Macrolides bind to the ribosome in the polypeptide exit tunnel (PET), which is the exit for the nascent peptide during protein synthesis, through a combination of hydrophobic and hydrophilic interactions. [5] [6] [7] [8] [9] [10] The most important interactions involve the desosamine sugar, present in all macrolides, and two bases in 23S rRNA. As shown in Scheme 1c, desosamine forms a hydrogen bond with N1 of A2058, although hydrogen bonding with N6 of A2058 or N1 of A2059 is also possible; desosamine also has an ionic interaction with the phosphate group of G2505. [1, 8, 10, 11] Macrolide binding blocks the PET and causes peptides to dissociate from the ribosome, preventing the synthesis of functional proteins. [11] [12] [13] Initially, macrolides were believed to block the passage of all peptides through the PET when they are 2-5 amino acids long. However, recent studies have shown that several proteins with specific N-terminal sequences can still be synthesized even when a macrolide is bound to the ribosome [14] [15] [16] [17] [18] and that protein synthesis can become interrupted at any | PAVLOVA et AL.
stage in response to specific stalling motifs. [19] The role of this selective protein inhibition in macrolide activity is presently unclear.
Unfortunately, resistance to macrolide antibiotics, caused by either efflux pumps [20] or ribosomal modifications, [2, [21] [22] [23] is a growing problem. Here we focus on the most common ribosomal modifications, which involve base A2058 in segment 23S. [1, [24] [25] [26] [27] [28] This base interacts directly with the macrolide, and the A2058G mutation or methylations of N6 of A2058 have been shown to dramatically reduce both binding and activity of erythromycin, azithromycin, and many other macrolides. [29] [30] [31] Both mutation and methylation of A2058 are believed to reduce hydrogen bonding between desosamine and base 2058, decreasing the macrolide's affinity for the ribosome. [7] [8] [9] [10] 32] However, there is also some evidence that displacement of the macrolide binding site due to steric clashes with the modified base could contribute to the decreased macrolide activity in resistant ribosomes. [33] The effect of the ribosomal modifications on bacterial resistance varies significantly for different bacteria types and macrolides. [26, 27, 30, 31, 34, 35] Nevertheless, combined studies of modified Escherichia coli ribosomes show that double methylation of N6 of A2058 is most effective in inducing resistance to erythromycin, followed by single methylation of N6 and lastly the A2058G mutation. [30, 31] Interest in combating bacterial resistance to macrolides has led to development of ketolides, which lack the cladinose sugar and commonly contain a linker attached to the macrolactone ring and an aromatic moiety (ARM), as shown in Scheme 1a-b. The most successful ketolides to date are telithromycin and solithromycin. [36, 37] Both of these compounds show increased activity against A2058G and singly methylated ribosomes, compared to erythromycin and azithromycin, although none of the present ketolides has shown sufficient activity against doubly methylated A2058 ribosomes. [30, 31, 35, 37] The increased activity of ketolides has been attributed to an increase in the affinity for the ribosome because of additional π-stacking interactions between the ARM and the base pair A752-U2609. [10, 31, 37] However, the position of the ARM in telithromycin varies for different crystal structures [9, 10, 38] and MD simulations also showed that this moiety is highly flexible. [32, 39] Although bacterial resistance to ketolides so far is rare, laboratory studies have demonstrated that high resistance can develop through deletion of A752 or mutation of U2609. [40, 41] It is highly advantageous to exploit interactions that are very important for the bacterial function in the design of future antibiotics, because ribosomal modifications that would perturb such interactions would also greatly decrease bacterial fitness. [42] We previously simulated the stalling peptide SecM in the ribosome and discovered the importance of stable aromatic interactions between residue W155 in SecM and base A751 in 23S rRNA for ribosomal stalling. [43] Our findings inspired the development of novel azithromycin derivatives containing indole-analog moieties that could mimic these interactions by Washington et al. [44] (Scheme 1b). Such derivatives are expected to compensate for the loss of interactions in mutated, azithromycin-resistant ribosomes, akin to the additional interactions formed by telithromycin. Some of these compounds, for example, COMP-2 in Scheme 1b, showed a higher half-maximal inhibitory concentration (IC 50 ) than azithromycin against E. coli ribosomes in cellfree assays, and the increased activity was attributed to π-stacking interactions between the indole-analog ARM and A751. Because adenine is an electron-rich aromatic compound, these interactions are expected to become more favorable if the ARM of the macrolide is made more electron deficient. [45] However, the experiments so far have shown the opposite; for example, the measured IC 50 s for COMP-2 and COMP-NO 2 in Scheme 1b and azithromycin are 0.157, 0.897, and 0.293 μm, respectively. [44] Similar increases in IC 50 were observed when substituting the nitro group with other electron-withdrawing substituents such as Cl or F. While the work of Washington et al. is very promising for development of new antibiotics with activities that are less susceptible to ribosomal modifications, a better understanding of the structure-activity relationship for the different indole analogs is desirable. Molecular dynamics (MD) simulation is a useful tool for studying molecular interactions of drugs in their binding sites. Complementary modeling of macrolides in combination with nuclear magnetic resonance or crystallography experiments has been done by several groups. [46] [47] [48] [49] [50] Also, detailed MD studies of interactions of oleandomycin, erythromycin, and roxithromycin with the ribosome or proteins have been performed. [51] [52] [53] [54] Lastly, Small et al. have employed MD simulations to study telithromycin in wild-type (WT) and in several A2058-modified macrolide-resistant ribosomes. [32] The simulations showed that ribosomal modifications can significantly alter the interactions between telithromycin and several bases of the 23S rRNA. The study showed a correlation between observed telithromycin resistance and reduced hydrogen bonding interactions between the desosamine of telithromycin and base 2058, concluding that the reduction of these interactions is the main cause of macrolide resistance. [32] The studies above used general force fields, such as CVFF, [55] GAFF, [56] or CGenFF [57] for the macrolides. We recently developed CHARMM-compatible force-field parameters for macrolides and validated them with simulations of the macrolides in the E. coli ribosome. [39] Our simulations showed improved maintenance of interactions between desosamine in the macrolide and the ribosome compared to the CGenFF parameters. However, some deviation of the macrolides' positions from the crystal structures was observed, especially in the case of telithromycin. In this study, we have performed MD simulations with our force-field parameters for the macrolides to investigate interactions of several macrolides with WT and macrolideresistant ribosomes. Specifically, erythromycin and azithromycin were simulated in WT, A2058G, and singly or doubly N6-methylated A2058 E. coli ribosomes. Additionally, the flexibility of telithromycin in the ribosome was investigated by a combination of MD simulations and quantum mechanical (QM) calculations. Lastly, the differences in binding of several azithromycin derivatives from Scheme 1b to the WT ribosome were identified.
| METHODS

| Molecular dynamics
NAMD 2.10 [58] was used for all simulations. We used CHARMM36 protein [59] and nucleic acid [60] force fields for the ribosome, the TIP3P model for water, [61] and our previously optimized force field for the macrolides. [39] CHARMM-compatible force-field parameters for methylated A2058 and other modified bases have been published previously. [62] To ensure accurate description of the rotation between the imidazole and the pyridine rings in the ARM of telithromycin, the dihedrals describing this rotation were reoptimized with the Force Field Toolkit (ffTK) plugin [63] in VMD at the MP2/6-31+G* level of theory (see Supporting Information), which was shown to correctly describe the orientation of the two aromatic rings in diazobenzene. [64] A Langevin thermostat and piston were used to keep the temperature and the pressure at the biologically relevant values of 310 K and 1 bar, respectively. The Langevin piston period was 300 fs and the piston decay was 150 fs. Rigid bonds were used for all covalent hydrogen bonds, allowing us to integrate the equations of motion with a 2-fs time step. The evaluation of short-range and long-range electrostatic interactions was carried out every step and every second step, respectively. Van der Waals interactions were cut off at 12 Å, and in order to ensure a smooth decay to zero, a switching function was applied from 10 to 12 Å. Long-range electrostatic interactions were calculated using the particlemesh Ewald method. [65] Analysis of non-bonded interaction energies was carried out using the NAMD energy plugin in VMD.
The erythromycin, azithromycin, and telithromycin systems were constructed from their corresponding PDB structures: 3OFR for erythromycin, [10] 3OHZ for azithromycin, [9] and 4V7S for telithromycin. [10] While 3OFR and 4V7S are from E. coli, 3OHZ is from Thermus thermophilus. Because the binding site of erythromycin in 3OFR is practically identical to azithromycin in 3OHZ, azithromycin was modeled into the E. coli ribosome based on the erythromycin structure. A reduced simulation system was created by extracting all ribosomal residues within at least 40 Å of the macrolide from the crystal structure of the complete macrolide-bound ribosome. The cut ends of proteins were acetylated and amidated at the N-and C-termini, respectively. Although crystallographic Mg 2+ ions were included, nearly 300 more were added at electrostatic minima using cIonize to neutralize the system. [66] The system was then solvated with water and KCl up to 7 Å beyond the ribosome on all sides. The mutated and methylated ribosome systems were created by mutating base 2058 in the WT systems with the Psfgen plugin in VMD and subsequently minimizing the energy of the new base.
The systems for the four azithromycin derivatives were created from our azithromycin system. The indole-analog moieties were added based on the position of W155 in our previous study of SecM [43] and a linker between azithromycin and the moiety was created with the Molefacture plugin in VMD.
The ribosome residues at the 40-Å boundary relative to the macrolide were restrained to their crystal structure positions with a force constant of 10 kcal/mol Å 2 for all simulations. In addition, softer restraints with a force constant of 2 kcal/mol Å 2 were added for residues within 34-39 Å of the macrolide. Similar restraints were used in previous telithromycin simulations by Small et al. [32] Because simulations of macrolides in the ribosome were shown to be sensitive to the initial conditions in our previous study, [39] energy minimization was done in two steps and extensive equilibration was done in five steps. In the first minimization step, all hydrogen atoms in the system were minimized, followed by a minimization of the macrolide, side chains of residues within 3 Å of the macrolide, water, and ions in the second step. After minimization, solvent and ions were equilibrated, followed by release of the restraints on the macrolide and the side chains of residues within 10 Å of the macrolide. In the final equilibration steps, the backbone outside of the permanently restrained region was restrained by successively smaller force constants of 5, 2, and 1 kcal/ mol Å 2 , while everything else was allowed to equilibrate. All equilibration steps were 4 ns long except the last step with a 1 kcal/mol Å 2 restraint on the backbone, which was 2 ns long.
After equilibration, several production runs of at least 50 ns were done for all macrolides studied here except telithromycin; see Table 1 for the total simulation time for each system. In total, 2.6 μs of simulations was performed. Because our WT telithromycin simulations showed significant flexibility of the aromatic moiety, which in turn resulted in breaking of interactions with the bases A2058 and G2505, the simulations were stopped early and the accuracy of our force fields for π-stacking interactions involving the imidazole-pyridine ARM of telithromycin and the indole-analog ARMs of the azithromycin derivatives was investigated with quantum mechanical (QM) calculations.
| Quantum mechanical calculations
To estimate the interaction energy between telithromycin and the A752-U2609 base pair in the E. coli ribosome, we performed QM calculations on a model derived from the Xray cocrystal structure (PDB entry 4V7S [10] ). In the model, the N-glycosidic linkages in the two nucleotides were truncated by replacing the glycosides with N-methyl groups to form 1-methyluracil and 9-methyladenine, respectively (Scheme S1). Similarly, telithromycin was truncated at the N-alkyl imidazolyl linkage with an N-methyl group to form 3-(1-methylimidazol-4-yl)pyridine. We also computed interaction energies for truncated models of COMP-2, represented by 1-methylindoline, and COMP-NO 2 , represented by 5-nitro-1-methylindole, with A751. Both parallel-displaced (PD) and T-shaped (T) orientations were considered, and A751 was represented by 9-methyladenine.
It has been shown previously [67] that dispersion-corrected density functional theory is capable of accurately reproducing the energies from the S66 × 8 benchmark set of noncovalent interaction energies. [68] In particular, the BLYP density functional [69, 70] and D3 empirical dispersion correction [71] with Becke-Johnson damping [71] (i.e., D3BJ)
provided an error of <0.2 kcal/mol when used with the def2-QZVP basis set. [72, 73] Furthermore, this level of theory outperformed several much more computationally demanding wave function theory approaches. Thus, after optimizing each system at the BLYP-D3BJ/def2-TZVP level of theory, we computed non-covalent interaction energies at the counterpoise-corrected BLYP-D3BJ/def2-QZVP level of theory. The resolution-of-the-identity approach with the W06 auxiliary basis set [73] was used to accelerate integral evaluation in all calculations. The geometries of the telithromycin-A752-U2609 (Fig.  S1 ), PD COMP-2-A751 (Fig. S2) , and PD COMP-NO 2 -A751 models (Fig. S3) were optimized without constraints. For the T-shaped complexes COMP-2-A751 (Fig. S4) and COMP-NO 2 -A751 (Fig. S5) , we first optimized the geometries of the monomers individually and then oriented the two monomers with custom TCL scripts using VMD. No further geometry optimizations were performed for the T complexes. Additional details are provided in the Supporting Information.
Counterpoise-corrected interaction energies (E int ) were then computed as where E comp is the energy of the complex, E tel is the energy of the telithromycin (or telithromycin analog) fragment, and E nucl is the energy of the nucleobase or base pair analog fragment.
Interaction energy curves were generated by scaling the interaction distance at the energy minimum for each complex (Figs S1-S5) by factors of 0.8, 0.9, 0.95, 1.0, 1.05, 1.1, 1.25, 1.5, 2.0, and 2.5. No further geometry optimizations were performed for the scaled complexes. The standard counterpoise approach [74] was applied to correct for basis set superposition error. All quantum chemical calculations were performed with Gaussian 09, Revision E.01, [75] using "UltraFine" grid, and "Tight" SCF settings. Non-bonded molecular mechanics (MM) interaction energies were calculated for the geometries taken from the QM calculations.
3 | RESULTS
| Erythromycin
Five 50-ns simulations with erythromycin were performed for each of the four ribosome models: WT, A2058G, and singly (Met1) and doubly (Met2) methylated A2058. Note that in the Met1 system, the methyl group can point either away from or toward the desosamine sugar in the macrolide, and the rotation barrier for the two orientations is high. [32] In our simulations, we only studied the case where the methyl group pointed toward the macrolide, which was shown to have more significant effects on interactions with base 2058. [32] Measurement of distances HB1, HB2, and HB3, defined in Schemes 1c and S2, was used to quantify the interactions of the macrolides with ribosome bases 2058 and 2059 through hydrogen bonding, while the ionic interaction with G2505 was estimated by the distance between N of the amino group in desosamine and P of the phosphate group in G2505 (see Figure 1) . Additionally, distributions of root-mean-square displacement (RMSD) of the macrolide from its position in the crystal structures, the angle between the planes of the purine rings of bases 2058 and 2059, and the non-bonded interaction energies between desosamine and base 2058 were calculated (Figure 2 ). It should be noted that calculation of non-bonded interaction energies between two moieties does not include thermal, entropic, or solvation effects and, therefore, is not a measurement of binding free energies. Nevertheless, these interaction energies are still useful for quantitative comparison. Our simulations of erythromycin in the WT ribosome showed high conservation of hydrogen bonding with A2058, mainly through HB1, and low RMSD of the
F I G U R E 1 Comparison of
interactions of erythromycin and azithromycin with residues 2058, A2059, and G2505 in WT, A2058G and singly or doubly methylated ribosomes by normalized distributions of distances HB1, HB2, HB3, and N-P (see Schemes 1c and S1 for definitions). Hydrogen bonding between N6 of A2058 and desosamine of the macrolides is not possible in Met1 and Met2 methylations, so HB2 was not plotted for these simulations. See Table S6 macrolide; however, significant fluctuations were observed for the ionic interaction. In comparison, the A2058G mutation resulted in similar interactions with A2058; there was a slight decrease in HB2 distance and a small increase in HB1 distance, while the ionic interaction distance was significantly decreased. Both Met1 and Met2 modifications led to a significant loss of interactions with base 2058 due to inaccessibility of short HB2 distances and a significant increase in HB1 distance, while an increase in interactions with A2059 through HB3 was also observed for Met1. Both methylations led to a decrease in the ionic interaction distance, compared to WT simulations, although this decrease was smaller than for the A2058G mutation. All ribosomal modifications showed increased RMSD of the macrolide from the crystal structure position and decreased non-bonded interaction energies between desosamine sugar and rRNA residue 2058 compared to the WT case. Both of these properties correlated well with the decreased macrolide activity for each mutation, suggesting that they could contribute to resistance. We also found that ribosomal modifications can affect the dynamics of bases 2058 and 2059. As shown in Figure 2 , the angle between the two purine rings of these bases fluctuates significantly for WT, Met1, and Met2 ribosomes, while the fluctuations are very small for the A2058G mutation.
| Azithromycin
Azithromycin was simulated in WT, A2058G, and singly or doubly methylated ribosome models with five 50-ns-long simulations performed for each ribosome system, as was done for erythromycin. Figures 1 and 2 show that azithromycin strongly resembles erythromycin in the WT ribosome and the trends for the different ribosomal modifications are also very similar for both macrolides. One difference is that our azithromycin simulations showed a larger increase in HB1 distance and interaction energy between residue 2058 and desosamine for the A2058G mutation compared to the WT ribosome, while this difference was small in the erythromycin simulations. Additionally, the RMSD was somewhat higher for azithromycin in all ribosomes, suggesting that this macrolide is more flexible in the binding site than erythromycin. Binding to the second azithromycin binding site, previously reported for Deinococcus radiodurans ribosomes, [8] was not observed in our simulations.
| Telithromycin
Our simulations of telithromycin in the WT ribosome model displayed frequent breaking of multiple interactions between telithromycin and A2058 as well as high RMSD (see Figure 3) . Therefore, the simulations were stopped after 25 ns, as we concluded that the telithromycin system exhibited too large fluctuations to effectively study the impact of ribosomal modifications on binding of telithromycin. Figure 4a , b illustrate the differences between telithromycin in crystal structure 4V7S and the configurations with high RMSD and broken interactions that were sampled in our simulations. As discussed in our previous study, [39] the breaking of the interactions with the ribosome and the high RMSD appear to correlate with the breaking of π-stacking interactions between the telithromycin ARM and A752. As shown in Figure 3b , d, the RMSD of only the ARM moiety is significantly higher than the RMSD of the whole telithromycin, whereas distances between the ARM and the bases A752 and U2609 are often too long for effective π−π interactions, which are expected to be favorable between 3 and 6 Å. [76, 77] The breaking of the A752-U2609 base pair is also often observed when π stacking with the ARM is broken.
To explain the flexibility of the telithromycin ARM observed in our simulations, we investigated the accuracy of our force field in describing the π-stacking interactions of the ARM. QM interaction energies between the ARM and A752-U2609 base pair at various distances were calculated and compared to molecular mechanics (MM) interaction energies, as described in the Methods section. The minimum QM interaction energy was −19.0 kcal/mol when the distance between H3 of U2609 and the plane of the imidazole ring (Scheme 2a) was 3.44 Å, whereas the minimum MM interaction energy was −10.6 kcal/mol at 3.79 Å (see Table   F Figure 4c shows that the interaction energies between the ARM and the A752-U2609 base pair are strongly underestimated by our force field at distances less than 5 Å. The MM interaction energies did not change significantly when we used CGenFF [57] parameters obtain by the PArAmchem program [78, 79] instead of our optimized parameters for the telithromycin ARM.
S1 for all energies).
| Azithromycin derivatives
Four azithromycin derivatives: COMP-2, COMP-H, COMP-Cl, and COMP-NO 2 (see Scheme 1b) were simulated in the WT ribosome model in order to elucidate the differences in their activity and to study their interactions with A751. Initially, two 50-ns simulations were performed for each of the compounds. In the first simulation of COMP-2, the ARM moved far away into PET instead of interacting with A751. Therefore, a third simulation of this compound was carried out in order to obtain better sampling of interactions with A751. Previously observed interactions between the azithromycin moiety and the ribosome were well maintained; we plot, for example, the frequency of interaction versus distance for HB1 (see Scheme 1c) for all derivatives in Fig. S7 . Table 2 shows the prevalence of different types of aromatic interactions for the four azithromycin derivatives. The presence and the type of stacking were defined by the angle between the two aromatic moieties and the center-of-mass distances commonly reported for aromatic stacking, [76, 77] as shown in Scheme 2b. Two dominant forms of π-stacking interactions, parallel and T-shaped (see Figure 5a , b), were observed for most compounds. T-shaped stacking was observed more often for the less active compounds, COMP-Cl and COMP-NO 2 , while the more active compounds, COMP-2 and COMP-H, displayed many varied interactions that could S C H E M E 2 (a) QM model system used to estimate the interaction energy between the ARM of telithromycin and rRNA bases A752-U2609.
The distance between H3 of U2609 and the imidazole ring of the ARM was used to measure the intermonomer separation (see Methods). (b) Definitions of parallel and T-shaped π stacking in our analysis. Parallel stacking is defined here as φ < 20° or φ < 160°, as well as r 1 < 6.0 Å. r 1 is defined as center-of-mass distance between the heavy atoms of the purine ring in A751 and the heavy atoms of the ARM. T-shaped stacking is defined as 70°< φ < 120° and r 2,3,4 < 50 Å. Because the center-of-mass distances between the two aromatic moieties during T-shaped stacking were significantly longer for COMP-NO 2 than for the other azithromycin derivatives, r 2 , r 3 , and r 4 distances were used instead of r 1 . These distances are defined as center-of-mass distances between the heavy atoms of the purine ring in A751 and either the top two hydrogens, H and Cl, or the NO 2 group of the ARM for r 2 , r 3 , and r 4 , respectively T A B L E 2 Fraction of appearance for the different types of interactions for the studied azithromycin derivatives and the experimental IC 50 s determined by Washington et al. [44] "All interactions" were defined as center-of-mass distances of less than 6 Å for the heavy atoms of the aromatic residues. See Scheme 2b for the definition of parallel and T-shaped interactions. "Other interactions" were calculated by subtracting the fractions of parallel and T-shaped interactions from the fraction of "all interactions" not be classified as either parallel or T-shaped (see Fig. S8 for examples). Parallel stacking was mostly observed for COMP-2 and COMP-NO 2 , which have very distinct activities. However, the position of the ARM during parallel stacking was significantly different for these compounds. In COMP-NO 2 , the nitro group of the ARM was always oriented toward N6 of A751 because of favorable electrostatic interactions, while for COMP-2 the ARM was pointed in the opposite direction (see Figure 5a , c), which in turn also affected the position of the linker relative to A751. COMP-Cl adopted similar parallel stacking geometries as COMP-NO 2 , although this stacking occurred rarely. Force-field accuracy for the interactions between A751 and indole derivatives was investigated by comparing QM and MM interaction energies of parallel and T-shaped stacking for the two most distinct moieties in our study: ARM-2 and ARM-NO 2 . As shown in Figure 6 , the MM interaction energies agree well with the QM values and the errors in the minimum interaction energies are less than 2 kcal/mol for all cases (see Tables S2-S5 for all energy values) . Parallel stacking energies are slightly underestimated for COMP-NO 2 , while the T-shaped interaction energies are underestimated for COMP-2 and overestimated COMP-NO 2 , explaining the differences in the observed T-shaped stacking in our simulations. Our simulations suggest that the higher experimental activities of COMP-H and COMP-2 are likely caused by the differences in the interactions with A751, namely the higher presence of unclassified interactions and the different ARM orientation in the parallel stacking of COMP-2.
| DISCUSSION
Erythromycin and azithromycin were simulated in the wild-type (WT) E. coli ribosome and in macrolide-resistant ribosome models containing an A2058G mutation or singly or doubly methylated N6 in A2058. Both macrolides exhibited very similar behavior in response to ribosomal modifications. Figures 1 and 2 show that, compared to the WT model, ribosomal modifications resulted in decreased hydrogen bonding and less favorable non-bonded energies between base 2058 and the desosamine sugar of the macrolides. Additionally, a bigger displacement of the macrolide from the crystal structures' position was observed. Strong correlations between decreased macrolide activity and interaction energies with residue 2058 as well as displacement of the macrolide from the crystal structure position were found for all studied ribosomal modifications. Therefore, our results suggest that macrolide resistance in A2058-modified ribosome is caused both by lower affinity of the ribosome for the macrolide, due to weaker interactions with residue 2058, and by spatial displacement of the macrolide in the PET. We also found that ribosomal modifications can have a significant effect on the angle between the two purine rings of residues 2058 and 2059 as shown in Figure 2 . An angle close to 160° is strongly favored for the A2058G mutation, whereas a wider range of angles was sampled for WT and methylated ribosomes. These differences in the structure and dynamics of ribosomal rRNA could affect macrolide binding and activity.
While decreased binding affinity of the macrolide for the ribosome is expected to decrease macrolide activity, the relationship between macrolide displacement and its activity is less apparent. We speculate that it could be related to the recently discovered selectivity of protein synthesis in macrolide-bound ribosomes. [15, 16] Unfortunately, it is presently not known how ribosomal modifications affect this selectivity. Future MD simulations of macrolides in WT and modified ribosomes in the presence of peptides that can and cannot bypass the macrolide in the PET could clarify the role of macrolide displacement and protein selectivity in macrolide-resistant ribosomes. The simulations of telithromycin in the ribosome showed loss of hydrogen bonds between desosamine and A2058 as well as loss of π stacking between the aromatic moiety (ARM) of telithromycin and the rRNA base pair A752-U2609; telithromycin's position also deviated significantly from the crystal structure position (see Figure 4) . Therefore, we concluded that the observed fluctuations in telithromycin's position and interactions with the ribosome were too high to allow meaningful comparison between WT and modified ribosomes. Additionally, previous simulations of telithromycin in WT and A2058-modified ribosomes by Small et al. [32] showed very similar trends regarding the conservation of hydrogen bonding and the ionic interaction with the ribosomes compared to our simulations of erythromycin and azithromycin. Hence, we did not expect any new observations from simulations of telithromycin in A2058-modified ribosomes. Instead, we investigated the accuracy of our force field in describing the π-stacking interactions of telithromycin. It was found that the non-bonded interactions between the ARM and the A752-U2609 base pair were significantly underestimated (by 8.5 kcal/mol) compared to the energies calculated with QM methods (see Figure 4c) .
In contrast to telithromycin, we found good agreement between QM and MM interaction energies for parallel and T-shaped stacking of A751 with two distinct aromatic indole derivatives: ARM-2 and ARM-NO 2 . The errors for the minimum interaction energies were less than 2 kcal/mol (see Figure 6 and Tables S2-S5 ). Hydrogen bonding with A2058 was mostly conserved for the studied azithromycin derivatives, suggesting that breaking of this interaction in the telithromycin simulations could be caused by an underestimation of π-stacking interactions, which increased the flexibility of the telithromycin ARM. Further investigation is needed to understand why only some π-stacking interaction energies are highly underestimated by force fields, and improvement of force-field parameters for aromatic moieties is needed for future studies of π-stacking drug-rRNA interactions in the ribosome. Such efforts are underway for, e.g., cation-π interactions. [80] Four azithromycin derivatives with indole-analog aromatic moieties (ARMs) developed by Washington et al. [44] (see Scheme 1b) were simulated in the WT ribosome in order to understand the lower activities of COMP-NO 2 and COMP-Cl, in spite of expected stronger π-stacking interactions. Our simulations showed two significant differences in the π-stacking interactions between the ARM and A751 for the four compounds that could explain the lower activities of COMP-NO 2 and COMP-Cl. First, parallel π stacking had different orientations of the ARM relative to A751 for COMP-NO 2 and COMP-Cl, compared to COMP-2 (see Figure 4a , c), which also affected the position of the linker. Second, in the simulations of COMP-2 and COMP-H a significant fraction of ARM-A751 interactions could not be quantified as either parallel or T-shaped. The different positions of the ARM and the linker could affect the macrolide's ability to block nascent peptides in the PET, while the additional unclassified ARM-A751 interactions of COMP-2 and COMP-H could lead to more favorable binding energies. It is unclear why parallel π stacking with A751 was not observed for COMP-H. Our results suggest that replacement of the indole derivatives with larger aromatic moieties could be a better strategy to improve the activities of COMP-H and COMP-2 than addition of electron-withdrawing substituents. It has been shown that the PET is spacious enough to accommodate translation of larger amino acids such as naphthylalanine. [81] Experimental testing of larger aromatic moieties would confirm our hypothesis. The present study illustrates how MD simulations can be used to elucidate the differences in the interactions of different macrolides with the ribosome and to identify the likely reasons for bacterial resistance caused by ribosomal modification. However, further force-field development is needed for accurate studies of π-stacking interactions of macrolides and ketolides containing aromatic moieties. We showed that mutations and methylations of rRNA residue A2058 could result in less favorable interaction energies of this base with the desosamine sugar in macrolides, displace the macrolide from its original position in the WT crystal structure, and alter the dynamics of bases 2058 and A2059 in 23S rRNA. Additionally, the differences in interactions with A751 for the azithromycin derivatives COMP-H and COMP-NO 2 were identified, and alterations to improve their efficacy were proposed. These alterations will be tested experimentally as part of successive rounds of simulation-influenced refinement.
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